Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.92 USD | +0.44% | +4.53% | +202.66% |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
May. 13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+202.66% | 359M | |
+38.92% | 723B | |
+34.02% | 595B | |
-3.10% | 369B | |
+20.66% | 332B | |
+2.84% | 282B | |
+17.32% | 244B | |
+9.43% | 208B | |
-4.70% | 205B | |
+0.49% | 168B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Evercore ISI Initiates Jasper Therapeutics With Outperform Rating, Price Target is $65